MedTrace Logo

Relationship Between Modality-specific Dual-task Performance and Immersive Exergaming Outcomes in Healthy Athletes

NCT07461025 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2026-04-01

No results posted yet for this study

Summary

The goal of this clinical trial is to provide a more specific understanding of which dual task conditions elicit changes in either motor or cognitive performance. A dual-task is a simultaneously performed motor and cognitive task. Exergaming describes physically active gaming. The main questions the study aims to answer are:

* Can performance in visual and auditory dual-task paradigms explain performance in an immersive exergaming task in healthy athletes?
* How are exergaming scores associated with athletic performance tests?
* What biomechanical movement patterns are shown during dual-tasks? Researchers will also compare performance of those experienced with jumping and those inexperienced with jumping.

Participants will:

* Complete two sessions performing athletic performance tests, cognitive tasks, and different dual-tasks while their movement pattern is recorded
* Complete questionnaires on load, stress, and sleep during the sessions

Conditions

  • Healthy Athlete

Interventions

OTHER

different dual-task paradigms

Participants will perform combined motor-cognitive tasks. During the first session balancing and bilateral jumping will be combined with an additional auditory or visual cognitive task. During the second session participants will do a combined motor-cognitive task in exergaming.

Sponsors & Collaborators

  • Zurich University of Applied Sciences

    lead OTHER

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
34 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-24
Primary Completion
2026-07-31
Completion
2026-08-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07461025 on ClinicalTrials.gov